Tuesday 27 November 2018

Week 170-172 review - Catchup after hols

I haven't got time to do a full run-down of the three weeks I was away, and they were a depressing three weeks for the market so I don't want to dwell on them anyway.

After Week 170 the portfolio value had dropped by £2,833 which widened the deficit to £6,210 and left the portfolio value at £89,089. Note that this is much higher than the week before, and that's because my pension transfer of £8,000 came through and I spent it. Turns out I should have waited a few weeks!

Firth thing was to buy another £5,180 shares in OPTI:Optibiotix at what seemed like a bargain price of 76.98p, costing £3,999.51. These subsequently dropped to 66p and I was terribly vexed.

Next was to increase my best run company and buy 893 shares on CAML:Central Asia Metals at 222.38p costing £1,997.80. Sad to watch these drop back to 208p since then.

Next was to ensure I hedged some gold, and what better than CEY:Centamin, buying another 1,057 at 94.8864p costing £1,014.90.

Finally I wanted to get into LLOY:Lloyds Bank now we're nearing the end of the PPI claiming period. I bought 1,663 at 59.09p costing £999.53 but Brexit scares have hit them already.

Week 171 was much more horrible, with the combined portfolios dropping £7,113 and widening the deficit to £13,323 at a total value of £81,983

Some good news from dividends, with TND:Tandem Group paying out £7.81 and TAP:Taptica paying £4.13.

Week 172 was less horrible, but still lost £1,004, widening the deficit to £14,327 and portfolio value stands at £80,979

I've updated the charts, but we'll do a bumper look at what's up and down later when next week's changes are clear.

Friday 2 November 2018

Week 169 Review - An upturn at last

About time there was some sort of turn around. The portfolio made up last week's losses and climbed £6,131 to close the deficit between cost and value to £3,377 and bring the portfolio value back up to £84,000.

Worst performer was last week's Share of the Week PAF:Pan African Resources, dropping a whopping 14% despite gold still doing quite well.

KIBO:Kibo Energy plunged 5% but it could have been much worse given TANESCO have obliterated the tenders and all this bollocks about "great relations with the Tanzanian government" is being revealed as hollow lies.

Only those two big fallers this week. Everything else good news. RED:RedT Energy and SAE:Simec Atlantis Energy both rose by 5% but have a hell of a way to go to get back to profit.

IQE:IQE went up by 9% and CAML:Central Asia Metals by 10% which was great given these are some of my biggest holdings. TAP:Taptica also climbed 10% in the trading account and is back in profit.

Share of the Week is OPTI:Optibiotix, and thank goodness. The 12% climb was responsible for most of this week's claw-back of the deficit.

OK - out of time to complete this, and off to Vietnam for 3 weeks in the morning, so I'll have to finish the snapshots when I get back and do a massive catch up. Fingers crossed when I next update I'll have my £8K pension transfer and OPTI:Optibiotix will have announced something amazing.








Week 168 Review - How can it keep getting worse?

Mega quick update as I'm behind a week and this week was so depressing. Value dropped by £6,171 making deficit between cost and value £9,508 and total portfolio value £77,869.

Worst performer was TAP:Taptica in the trading account which plunged to a loss, dropping 12% for no reason.

OPTI:Optibiotix fell another 11% and is only just in profit. This had most of the negative impact and is utterly depressing.

CAML:Central Asia Metals also had a dreadful week, dropping 6% along with AMYT:Amryt Pharma

SBTX:SkinBioTherapeutics and SAE:Simec Atlantis Energy fell 5%.

Only one share did anything, and to show how bad a week it was, Share of the Week PAF:Pan African Resources only climbed 4%.




Horrid

Here's the ISA and share account performances



Weekly Change
Cash £25.99
+£0
Portfolio cost £56,958.55
+£0
Portfolio sell value (bid price - commission) £49,558.31 (-13%) -£4,053.78
Potential profits £2,259.65
-£3,541.72
Yr 4 Dividends £52.69
+£0
Yr 4 Profit from sales £814.53
+£0
Yr 4 Average monthly cash profit £309.10 (6.5%) -£28.10
Total Dividends £1,291.02
+£0
Total Profit from sales £19,511.65
+£0
Average monthly cash profit £532.51 (11.2%) -£3.18
(Sold stocks profit + Dividends - Fees / Months)

Bad, bad, bad - everywhere




Yuck

Here's the SIPP after week 152



Weekly Change
Cash £163.74
+£133.58
Portfolio cost £27,893.76
+£0
Portfolio sell value (bid price - commission) £26,440.30 (-5.2%) -£2,004.81
Potential profits £2,282.83
-£1,860.10
Yr 3 Dividends £426.15
+£133.58
Yr 3 Profit from sales £1,619.73
+£0
Yr 3 Average monthly cash profit £173.55 (7.5%) +£8.62
Total Dividends £1,342.25
+£133.58
Total Profit from sales £10,544.92
+£0
Average monthly cash profit £331.16 (14.2%) +£1.64
(Sold stocks profit + Dividends - Fees / Months)

One fragment of good news was the £133 dividend from CAML:Central Asia Metals, taking my total dividend yield from that share to £986 which is pretty amazing. Much misery elsewhere though.




Plunges to loss for first time in ages

The trading account looks like this after week 118



Weekly Change
Cash £14.67
+£13.20
Portfolio cost £2,321.29
+£0
Portfolio sell value (bid price - commission) £1,666.12 (-28.2%) -£112.96
Potential profits £0
-£18.96
Year 3 Dividends £13.20
+£13.20
Year 3 Profit £177.06
+£0
Yr 3 Average monthly cash profit £54.80 (30.4%) -£4.22
Dividends £14.35
+£13.20
Profit from sales -£64.29
+£0
Average monthly cash profit -£2.32 (-0.9%) +£0.02
(Sold stocks profit + Dividends - Fees / Months)

Big drop and no potential profit.



Desperate

hat's it - not writing any more as I need to catch up this week, and it's more fun.